NCT00869388 A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00858377 A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00847366 Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma Status COMPLETED Phase NA
NCT00839631 Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00832780 Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung Status COMPLETED Phase NA
NCT00828919 Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials Status COMPLETED Phase NA
NCT00819221 AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours Status TERMINATED Phase PHASE1
NCT00819169 QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT00807859 Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00805636 Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. Status UNKNOWN Phase PHASE2
NCT00801177 Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy Status COMPLETED Phase PHASE1
NCT00791154 QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00791063 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT Status COMPLETED Phase PHASE2
NCT00778128 A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour Status COMPLETED Phase PHASE1
NCT00776867 Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors Status COMPLETED Phase PHASE1
NCT00773929 Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer Status COMPLETED Phase PHASE1